Highlights
NASDAQ: DMPI       Delmar Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
0.63   -0.002 (0.32%)  0.63 - 0.656  314,900

Overview

 
Avg Volume (4 weeks):249,833
4 Weeks Range:0.513 - 0.723
4 Weeks Price Volatility (%):
55.71%
52 Weeks Range:0.281 - 5.75
52 Weeks Price Volatility (%):
6.38%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

DelMar Pharmaceuticals Inc is a clinical and commercial stage drug development company, which focuses on the research and development of drugs for the treatment of cancer. The company's principal product candidate includes VAL-083, a small-molecule chemotherapeutic agent, which is in clinical trials stage for the treatment of refractory glioblastoma multiforme, a form of brain cancer. DelMar also has a strategic collaboration with Guangxi Wuzhou Pharmaceutical for the development of VAL-083 used in treating chronic myelogenous leukemia and lung cancer. All the business activity of the firm is functioned through the region of Canada.

  Be the first to like this.
 


 

3414  4674  636  186 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.67+0.30 
 TTNP 0.334+0.084 
 SPY 331.95+1.03 
 SNCA 1.60+0.35 
 EEM 46.23+0.26 
 AVP 5.60-0.05 
 AMD 50.93+1.16 
 CHK 0.661-0.029 
 BAC 34.71-0.01 
 GE 11.81-0.03 
Partners & Brokers